AMENDMENT NO. 1 TO AGREEMENT AND PLAN OF MERGERAgreement and Plan of Merger • November 18th, 2015 • Zeneca, Inc. • Pharmaceutical preparations
THIS AMENDMENT NO. 1 to Agreement and Plan of Merger (this “Amendment”) is entered into as of November 17, 2015, among Zeneca, Inc., a Delaware corporation (“Parent”), Zanzibar Acquisition Corp., a Delaware corporation and a wholly owned subsidiary of Parent (“Merger Sub”), and ZS Pharma, Inc., a Delaware corporation (the “Company”).
CONFIDENTIALITY AGREEMENT (Mutual Disclosure)Confidentiality Agreement • November 18th, 2015 • Zeneca, Inc. • Pharmaceutical preparations • Delaware
THIS CONFIDENTIALITY AGREEMENT (the “Agreement”) is made and entered into as of September 23, 2015 (the “Effective Date”) by and between ZS Pharma, Inc., with principal offices located at 508 Wrangler Drive, Suite 100, Coppell, TX 75019 (“ZS Pharma”) and AstraZeneca Pharmaceuticals LP with principal offices located at 1800 Concord Pike, Wilmington, DE 19850 (“Counterparty”). Each of ZS Pharma and Counterparty is hereinafter referred to individually as a “Party” and collectively as the “Parties”.
